Ivy N Haskins1, Andrew T Strong1, Matthew T Allemang1, Kalman P Bencsath1,2, John H Rodriguez1, Matthew D Kroh3,4,5. 1. Section of Surgical Endoscopy, Department of General Surgery, The Cleveland Clinic Foundation, Cleveland Clinic, 9500 Euclid Avenue, A-100, Cleveland, OH, 44195, USA. 2. Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA. 3. Section of Surgical Endoscopy, Department of General Surgery, The Cleveland Clinic Foundation, Cleveland Clinic, 9500 Euclid Avenue, A-100, Cleveland, OH, 44195, USA. KrohM@ClevelandClinicAbuDhabi.ae. 4. Department of General Surgery, Cleveland Clinic-Abu Dhabi, Abu Dhabi, United Arab Emirates. KrohM@ClevelandClinicAbuDhabi.ae. 5. Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA. KrohM@ClevelandClinicAbuDhabi.ae.
Abstract
INTRODUCTION: Magnet-assisted surgery is a new platform within minimally invasive surgery. The Levita™ Magnetic Surgical System, the first magnetic surgical system to receive Food and Drug Administration (FDA) approval, includes a deployable, magnetic grasper and an external magnet that is used to manipulate the grasper within the peritoneal cavity. This system is currently approved for patients undergoing laparoscopic cholecystectomy with a body mass index (BMI) between 21 and 34 kg/m2. Herein, we detail the first United States experience with the Levita™ Magnetic Surgical System during laparoscopic cholecystectomy. METHODS: The Levita™ Magnetic Surgical System was used on consecutive patients undergoing laparoscopic cholecystectomy at our institution from June 2016 through November 2016. Only patients undergoing elective surgery and those with a body mass index (BMI) between 21 and 34 kg/m2 were included. Baseline patient characteristics, operative time, and perioperative details were collected. RESULTS: A total of ten patients underwent laparoscopic cholecystectomy with the Levita™ Magnetic Surgical System during the defined study period. The mean age at the time of surgery was 49.0 years and the average BMI of the cohort was 27.6 kg/m2. The average operative time was 64.4 min. There were no perioperative complications. Seven (70.0%) patients were discharged to home on the day of surgery, while the remaining three (30.0%) patients were discharged to home on postoperative day number one. Surgeons reported that the magnetic grasper was easy to use and provided adequate tissue retraction and exposure. CONCLUSIONS: The Levita™ Magnetic Surgical System is safe and feasible to use in patients undergoing laparoscopic cholecystectomy. Routine use of this system may facilitate a reduction in the total number of laparoscopic trocars used, leading to less tissue trauma and improved cosmesis. Additional studies are needed to determine the applicability and utility of this system for other general surgery cases.
INTRODUCTION: Magnet-assisted surgery is a new platform within minimally invasive surgery. The Levita™ Magnetic Surgical System, the first magnetic surgical system to receive Food and Drug Administration (FDA) approval, includes a deployable, magnetic grasper and an external magnet that is used to manipulate the grasper within the peritoneal cavity. This system is currently approved for patients undergoing laparoscopic cholecystectomy with a body mass index (BMI) between 21 and 34 kg/m2. Herein, we detail the first United States experience with the Levita™ Magnetic Surgical System during laparoscopic cholecystectomy. METHODS: The Levita™ Magnetic Surgical System was used on consecutive patients undergoing laparoscopic cholecystectomy at our institution from June 2016 through November 2016. Only patients undergoing elective surgery and those with a body mass index (BMI) between 21 and 34 kg/m2 were included. Baseline patient characteristics, operative time, and perioperative details were collected. RESULTS: A total of ten patients underwent laparoscopic cholecystectomy with the Levita™ Magnetic Surgical System during the defined study period. The mean age at the time of surgery was 49.0 years and the average BMI of the cohort was 27.6 kg/m2. The average operative time was 64.4 min. There were no perioperative complications. Seven (70.0%) patients were discharged to home on the day of surgery, while the remaining three (30.0%) patients were discharged to home on postoperative day number one. Surgeons reported that the magnetic grasper was easy to use and provided adequate tissue retraction and exposure. CONCLUSIONS: The Levita™ Magnetic Surgical System is safe and feasible to use in patients undergoing laparoscopic cholecystectomy. Routine use of this system may facilitate a reduction in the total number of laparoscopic trocars used, leading to less tissue trauma and improved cosmesis. Additional studies are needed to determine the applicability and utility of this system for other general surgery cases.
Entities:
Keywords:
Feasibility; Magnetic surgery; Minimally invasive surgery; Safety
Authors: Sara L Best; Richard Bergs; Daniel J Scott; Raul Fernandez; Lauren B Mashaud; Jeffrey A Cadeddu Journal: J Endourol Date: 2011-12-28 Impact factor: 2.942
Authors: Jonathan T Carter; Jennifer A Kaplan; Jason N Nguyen; Matthew Y C Lin; Stanley J Rogers; Hobart W Harris Journal: J Am Coll Surg Date: 2014-02-19 Impact factor: 6.113
Authors: Oscar Vidal; Mauro Valentini; Juan J Espert; Cesar Ginesta; Jaime Jimeno; Alberto Martinez; Guerson Benarroch; Juan C Garcia-Valdecasas Journal: J Laparoendosc Adv Surg Tech A Date: 2009-10 Impact factor: 1.878
Authors: Homero Rivas; Ignacio Robles; Francisco Riquelme; Marcelo Vivanco; Julio Jiménez; Boris Marinkovic; Mario Uribe Journal: Ann Surg Date: 2018-01 Impact factor: 12.969
Authors: Leonard K Welsh; Gerardo Davalos; Ramon Diaz; Andres Narvaez; Juan Esteban Perez; Melissa Castro; Maragatha Kuchibhatla; Thomas Risoli; Dana Portenier; Alfredo D Guerron Journal: J Laparoendosc Adv Surg Tech A Date: 2020-07-14 Impact factor: 1.878